Epidemiological risk factors associated with inflammatory breast cancer subtypes
- PMID: 26797453
- PMCID: PMC4778706
- DOI: 10.1007/s10552-015-0712-3
Epidemiological risk factors associated with inflammatory breast cancer subtypes
Abstract
Background: In this single-institution case-control study, we identified risk factors associated with inflammatory breast cancer (IBC) subtypes based on staining of estrogen receptor (ER), progesterone receptor (PR) and expression of human epidermal growth factor 2 (HER2neu) to determine distinct etiologic pathways.
Methods: We identified 224 women with IBC and 396 cancer-free women seen at the MD Anderson Cancer Center. Multinomial logistic regression was used to estimate odds ratios (ORs) and 95 % confidence intervals (CIs) for associations between breast cancer risk factors and the IBC tumor subtypes: luminal (ER+ and/or PR+/HER2neu-), HER2neu+ (any ER and PR, HER2neu+), and triple-negative (ER-/PR-/HER2neu-).
Results: In multivariable analysis, compared with women age ≥26 at first pregnancy, women age <26 had a higher risk of triple-negative IBC (OR 3.32, 95% CI 1.37-8.05). Women with a history of breast-feeding had a lower risk of triple-negative (OR 0.30; 95% CI 0.15-0.62) and luminal IBC (OR 0.35, 95% CI 0.18-0.68). A history of smoking was associated with an increased risk of luminal IBC (OR 2.37; 95% CI 1.24-4.52). Compared with normal-weight women, those who were overweight or obese (body mass index ≥25 kg/m(2)) had a higher risk of all three tumor subtypes (p < 0.01 for all subtypes).
Conclusion: Overweight or obese status is important modifiable risk factor for IBC of any subtype. Modifiable risk factors, age at first pregnancy (≥26), breast-feeding, and smoking may be associated with specific IBC subtypes. These results highlight the importance of evaluating epidemiologic risk factors for IBC for the identification of subtype-specific prevention strategies.
Keywords: Cancer epidemiology; Inflammatory breast cancer; Lifestyle factors; Obesity; Reproductive factors.
Similar articles
-
Reproductive Risk Factors of Inflammatory Breast Cancer according to Luminal, HER2-Overexpressing, and Triple-Negative Subtypes: A Case Comparison Study.Oncol Res Treat. 2020;43(5):204-210. doi: 10.1159/000506691. Epub 2020 Mar 23. Oncol Res Treat. 2020. PMID: 32203954
-
Association between common risk factors and molecular subtypes in breast cancer patients.Breast. 2013 Jun;22(3):344-50. doi: 10.1016/j.breast.2012.08.005. Epub 2012 Sep 14. Breast. 2013. PMID: 22981738
-
Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.Breast Cancer Res. 2017 Jan 23;19(1):10. doi: 10.1186/s13058-016-0798-x. Breast Cancer Res. 2017. PMID: 28114999 Free PMC article.
-
Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies.Cancer Treat Rev. 2016 Sep;49:65-76. doi: 10.1016/j.ctrv.2016.07.006. Epub 2016 Jul 29. Cancer Treat Rev. 2016. PMID: 27529149 Review.
-
Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysis.Ann Oncol. 2015 Dec;26(12):2398-407. doi: 10.1093/annonc/mdv379. Epub 2015 Oct 26. Ann Oncol. 2015. PMID: 26504151 Free PMC article. Review.
Cited by
-
Epigenetics in Inflammatory Breast Cancer: Biological Features and Therapeutic Perspectives.Cells. 2020 May 8;9(5):1164. doi: 10.3390/cells9051164. Cells. 2020. PMID: 32397183 Free PMC article. Review.
-
Inflammatory breast cancer appearance at presentation is associated with overall survival.Cancer Med. 2021 Sep;10(18):6261-6272. doi: 10.1002/cam4.4170. Epub 2021 Jul 30. Cancer Med. 2021. PMID: 34327874 Free PMC article.
-
Cancer in Guam and Hawaii: A comparison of two U.S. Island populations.Cancer Epidemiol. 2017 Oct;50(Pt B):199-206. doi: 10.1016/j.canep.2017.08.005. Cancer Epidemiol. 2017. PMID: 29120826 Free PMC article.
-
Accumulation of Arachidonic Acid, Precursor of Pro-Inflammatory Eicosanoids, in Adipose Tissue of Obese Women: Association with Breast Cancer Aggressiveness Indicators.Biomedicines. 2022 Apr 26;10(5):995. doi: 10.3390/biomedicines10050995. Biomedicines. 2022. PMID: 35625732 Free PMC article.
-
RIPK2: New Elements in Modulating Inflammatory Breast Cancer Pathogenesis.Cancers (Basel). 2018 Jun 5;10(6):184. doi: 10.3390/cancers10060184. Cancers (Basel). 2018. PMID: 29874851 Free PMC article.
References
-
- Low JA, Berman AW, Steinberg SM, Danforth DN, Lippman ME, Swain SM. Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. J Clin Oncol. 2004;22:4067–74. - PubMed
-
- Natori A, Hayashi N, Soejima K, Deshpande GA, Takahashi O, Cristofanilli M, et al. A comparison of epidemiology, biology, and prognosis of inflammatory breast cancer in Japanese and US populations. Clinical breast cancer. 2013;13:460–4. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous